Steven E Nissen. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Cardiovascular Diseases/chemically inducedCyclooxygenase 2 Inhibitors/adverse effectsData Interpretation, StatisticalHumansLactones/adverse effectsRandomized Controlled Trials as TopicSulfones/adverse effects
Substances: See more » Cyclooxygenase 2 InhibitorsLactonesSulfonesrofecoxib
Year: 2006 PMID: 16801355 DOI: 10.1056/NEJMc066260
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245